TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
SARomics Biostructures AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
29,075
|
25,147
|
22,326 |
Financial expenses |
19
|
533
|
84 |
Earnings before taxes |
951
|
2,566
|
1,651 |
EBITDA |
1,203
|
3,208
|
2,386 |
Total assets |
15,846
|
14,780
|
13,712 |
Current assets |
11,004
|
10,839
|
9,327 |
Current liabilities |
6,405
|
6,575
|
7,209 |
Equity capital |
8,911
|
7,640
|
5,901 |
- share capital |
138
|
129
|
133 |
Employees (average) |
27
|
22
|
20 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
56.2%
|
51.7%
|
43.0% |
Turnover per employee |
1,077
|
1,143
|
1,116 |
Profit as a percentage of turnover |
3.3%
|
10.2%
|
7.4% |
Return on assets (ROA) |
6.1%
|
21.0%
|
12.7% |
Current ratio |
171.8%
|
164.9%
|
129.4% |
Return on equity (ROE) |
10.7%
|
33.6%
|
28.0% |
Change turnover |
2,144
|
3,492
|
3,706 |
Change turnover % |
8%
|
16%
|
20% |
Chg. No. of employees |
5
|
2
![]() |
2 |
Chg. No. of employees % |
23%
|
10%
|
11% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.